Cebpb | Mouse | (-)-cotinine | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | [Nicotine results in increased abundance of Cotinine] which results in increased expression of CEBPB mRNA | CTD | PMID:29617909 |
Cebpb | Mouse | (R)-adrenaline | decreases expression | EXP | | 6480464 | Epinephrine results in decreased expression of CEBPB protein | CTD | PMID:31520687 |
Cebpb | Mouse | (S)-amphetamine | increases expression | EXP | | 6480464 | Dextroamphetamine results in increased expression of CEBPB mRNA | CTD | PMID:12558987 |
Cebpb | Mouse | (S)-nicotine | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Nicotine results in increased expression of CEBPB mRNA | CTD | PMID:18805435 |
Cebpb | Mouse | (S)-nicotine | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | [Nicotine results in increased abundance of Cotinine] which results in increased expression of CEBPB mRNA | CTD | PMID:29617909 |
Cebpb | Mouse | 1,1-dichloroethene | increases expression | EXP | | 6480464 | vinylidene chloride results in increased expression of CEBPB mRNA | CTD | PMID:26682919 |
Cebpb | Mouse | 1,2,4-trimethylbenzene | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | pseudocumene results in increased expression of CEBPB protein | CTD | PMID:17337753 |
Cebpb | Mouse | 1,2-dimethylhydrazine | increases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of CEBPB mRNA | CTD | PMID:22206623 |
Cebpb | Mouse | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CEBPB mRNA | CTD | PMID:22206623 |
Cebpb | Mouse | 1-naphthyl isothiocyanate | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of CEBPB mRNA | CTD | PMID:27344345 |
Cebpb | Mouse | 1-nitropyrene | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | 1-nitropyrene results in increased expression of CEBPB mRNA | CTD | PMID:19428942 |
Cebpb | Mouse | 14-Deoxy-11,12-didehydroandrographolide | multiple interactions | EXP | | 6480464 | 14-deoxy-11 more ... | CTD | PMID:30248417 |
Cebpb | Mouse | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of CEBPB mRNA | CTD | PMID:17942748 |
Cebpb | Mouse | 17alpha-ethynylestradiol | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Ethinyl Estradiol results in increased expression of CEBPB mRNA | CTD | PMID:17351261 |
Cebpb | Mouse | 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CEBPB mRNA | CTD | PMID:17942748 |
Cebpb | Mouse | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of CEBPB mRNA | CTD | PMID:15289156 more ... |
Cebpb | Mouse | 17beta-estradiol | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Estradiol results in increased expression of CEBPB mRNA | CTD | PMID:32145629 |
Cebpb | Mouse | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of CEBPB mRNA | CTD | PMID:19484750 |
Cebpb | Mouse | 17beta-estradiol | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Estradiol results in increased expression of CEBPB mRNA | CTD | PMID:23373633 |
Cebpb | Mouse | 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of CEBPB mRNA | CTD | PMID:15598610 |
Cebpb | Mouse | 17beta-estradiol | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [Estradiol co-treated with Norethindrone Acetate] results in increased expression of CEBPB mRNA more ... | CTD | PMID:17395694 and PMID:22217510 |
Cebpb | Mouse | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with 2 more ... | CTD | PMID:28433925 |
Cebpb | Mouse | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:24559133 |
Cebpb | Mouse | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | EXP | | 6480464 | 2 more ... | CTD | PMID:30294300 |
Cebpb | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CEBPB mRNA | CTD | PMID:14505802 more ... |
Cebpb | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CEBPB mRNA | CTD | PMID:27913140 |
Cebpb | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CEBPB mRNA | CTD | PMID:16263508 and PMID:17823287 |
Cebpb | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of CEBPB mRNA | CTD | PMID:20702594 and PMID:21570461 |
Cebpb | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CEBPB mRNA | CTD | PMID:22298810 and PMID:34747641 |
Cebpb | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CEBPB mRNA and Tetrachlorodibenzodioxin results in increased expression of CEBPB protein | CTD | PMID:19692669 and PMID:21777668 |
Cebpb | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | geldanamycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of [[CEBPB protein binds to CEBPB protein] which binds to PTGS2 promoter]] more ... | CTD | PMID:11133817 and PMID:21777668 |
Cebpb | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | increases activity | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased activity of CEBPB protein | CTD | PMID:14505802 |
Cebpb | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CEBPB mRNA and Tetrachlorodibenzodioxin results in decreased expression of CEBPB protein | CTD | PMID:12758056 and PMID:14708085 |
Cebpb | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | increases response to substance | EXP | | 6480464 | CEBPB protein results in increased susceptibility to Tetrachlorodibenzodioxin | CTD | PMID:11979424 |
Cebpb | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CEBPB protein] more ... | CTD | PMID:12758056 more ... |
Cebpb | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | increases activity | ISO | CEBPB (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased activity of CEBPB protein | CTD | PMID:19147701 |
Cebpb | Mouse | 2,3,7,8-Tetrachlorodibenzofuran | affects expression | EXP | | 6480464 | 2 more ... | CTD | PMID:20702594 |
Cebpb | Mouse | 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CEBPB mRNA] | CTD | PMID:18200517 |
Cebpb | Mouse | 2,4,6-trinitrobenzenesulfonic acid | increases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in increased expression of CEBPB mRNA | CTD | PMID:18200517 |
Cebpb | Mouse | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | multiple interactions | EXP | | 6480464 | 2 more ... | CTD | PMID:30903904 |
Cebpb | Mouse | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | EXP | | 6480464 | 2 more ... | CTD | PMID:38648751 |
Cebpb | Mouse | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:26705709 |
Cebpb | Mouse | 2-acetamidofluorene | decreases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | 2-Acetylaminofluorene results in decreased expression of CEBPB protein | CTD | PMID:21785164 |
Cebpb | Mouse | 2-acetamidofluorene | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | 2-Acetylaminofluorene inhibits the reaction [CEBPB protein binds to HAMP promoter] | CTD | PMID:21785164 |
Cebpb | Mouse | 2-bromohexadecanoic acid | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | 2-bromopalmitate promotes the reaction [Tretinoin results in increased expression of CEBPB mRNA] | CTD | PMID:30076181 |
Cebpb | Mouse | 2-butoxyethanol | increases expression | EXP | | 6480464 | n-butoxyethanol results in increased expression of CEBPB mRNA | CTD | PMID:19812364 |
Cebpb | Mouse | 2-methylcholine | affects expression | ISO | CEBPB (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of CEBPB mRNA | CTD | PMID:21179406 |
Cebpb | Mouse | 3',5'-cyclic AMP | increases response to substance | EXP | | 6480464 | CEBPB protein results in increased susceptibility to Cyclic AMP | CTD | PMID:23097472 |
Cebpb | Mouse | 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | 3 more ... | CTD | PMID:19692669 |
Cebpb | Mouse | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of CEBPB mRNA | CTD | PMID:30071829 |
Cebpb | Mouse | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | 1-Methyl-3-isobutylxanthine promotes the reaction [FSHB protein results in increased expression of CEBPB protein] | CTD | PMID:25253736 |
Cebpb | Mouse | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CEBPB mRNA and [Vitamin D co-treated with bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CEBPB mRNA | CTD | PMID:28628672 and PMID:33836827 |
Cebpb | Mouse | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | 14-deoxy-11 more ... | CTD | PMID:16054899 more ... |
Cebpb | Mouse | 3-methylcholanthrene | multiple interactions | EXP | | 6480464 | [Capsaicin results in increased activity of CEBPB protein] inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA] and [Capsaicin results in increased activity of CEBPB protein] inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 protein] | CTD | PMID:21250977 |
Cebpb | Mouse | 3H-1,2-dithiole-3-thione | decreases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | 1 and 2-dithiol-3-thione results in decreased expression of CEBPB mRNA | CTD | PMID:19162173 |
Cebpb | Mouse | 4,4'-sulfonyldiphenol | increases expression | EXP | | 6480464 | bisphenol S results in increased expression of CEBPB mRNA | CTD | PMID:30951980 |
Cebpb | Mouse | 4,4'-sulfonyldiphenol | affects expression | EXP | | 6480464 | bisphenol S affects the expression of CEBPB mRNA | CTD | PMID:39298647 |
Cebpb | Mouse | 4-hydroxyphenyl retinamide | increases expression | EXP | | 6480464 | Fenretinide results in increased expression of CEBPB mRNA | CTD | PMID:28973697 |
Cebpb | Mouse | 4-phenylbutyric acid | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | 4-phenylbutyric acid inhibits the reaction [honokiol results in decreased activity of CEBPB protein] | CTD | PMID:34973135 |
Cebpb | Mouse | 5-aza-2'-deoxycytidine | affects expression | ISO | CEBPB (Homo sapiens) | 6480464 | Decitabine affects the expression of CEBPB mRNA | CTD | PMID:23300844 |
Cebpb | Mouse | 5-fluorouracil | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Fluorouracil results in increased expression of CEBPB mRNA | CTD | PMID:16557594 more ... |
Cebpb | Mouse | 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide | decreases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | 6-chloro-2 more ... | CTD | PMID:29653943 |
Cebpb | Mouse | 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | DDIT3 protein affects the reaction [6-chloro-2 more ... | CTD | PMID:29653943 |
Cebpb | Mouse | 6-propyl-2-thiouracil | decreases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of CEBPB mRNA and Propylthiouracil results in decreased expression of CEBPB protein | CTD | PMID:26459835 and PMID:33150595 |
Cebpb | Mouse | 6-propyl-2-thiouracil | increases methylation | ISO | Cebpb (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased methylation of CEBPB promoter | CTD | PMID:33150595 |
Cebpb | Mouse | 8-(4-chlorophenylthio)-cGMP | increases expression | EXP | | 6480464 | 8-((4-chlorophenyl)thio)cyclic-3' and 5'-GMP results in increased expression of CEBPB protein | CTD | PMID:20471953 |
Cebpb | Mouse | 8-(4-chlorophenylthio)-cGMP | multiple interactions | EXP | | 6480464 | 8-(4-chlorophenylthio)guanosine 3' more ... | CTD | PMID:20471953 |
Cebpb | Mouse | 9-cis-retinoic acid | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | [9-deoxy-delta-9-prostaglandin D2 co-treated with Alitretinoin] results in increased activity of CEBPB protein | CTD | PMID:15150131 |
Cebpb | Mouse | acetaldehyde | multiple interactions | EXP | | 6480464 | Acetaldehyde promotes the reaction [CEBPB protein binds to COL1A1 enhancer] | CTD | PMID:10613735 |
Cebpb | Mouse | acetaldehyde | increases expression | EXP | | 6480464 | Acetaldehyde results in increased expression of CEBPB protein | CTD | PMID:10613735 |
Cebpb | Mouse | acetaldehyde | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | [Acetaldehyde promotes the reaction [CEBPB protein binds to COL1A1 promoter]] which results in increased expression of COL1A1 mRNA and Acetaldehyde promotes the reaction [CEBPB protein binds to COL1A1 promoter] | CTD | PMID:10871045 |
Cebpb | Mouse | acetylsalicylic acid | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | Aspirin promotes the reaction [CEBPB protein binds to IL4 promoter polymorphism] | CTD | PMID:20921925 |
Cebpb | Mouse | acrolein | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Acrolein results in increased expression of CEBPB mRNA | CTD | PMID:38090360 |
Cebpb | Mouse | acrylamide | multiple interactions | EXP | | 6480464 | Acrylamide promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of CEBPB protein] and Acrylamide promotes the reaction [Dietary Fats results in increased phosphorylation of CEBPB protein] | CTD | PMID:30409764 |
Cebpb | Mouse | acrylamide | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Acrylamide results in increased expression of CEBPB mRNA | CTD | PMID:32763439 |
Cebpb | Mouse | actinomycin D | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Dactinomycin results in decreased expression of CEBPB mRNA | CTD | PMID:16001973 |
Cebpb | Mouse | aflatoxin B1 | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Aflatoxin B1 results in increased expression of CEBPB mRNA | CTD | PMID:33354967 |
Cebpb | Mouse | aflatoxin B1 | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of CEBPB mRNA | CTD | PMID:32234424 |
Cebpb | Mouse | AICA ribonucleotide | increases phosphorylation | ISO | CEBPB (Homo sapiens) | 6480464 | AICA ribonucleotide results in increased phosphorylation of CEBPB protein | CTD | PMID:28038998 |
Cebpb | Mouse | aldehydo-D-glucose | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | CEBPB protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein] more ... | CTD | PMID:24376792 |
Cebpb | Mouse | aldehydo-D-glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of CEBPB protein | CTD | PMID:29266779 |
Cebpb | Mouse | aldehydo-D-glucose | multiple interactions | EXP | | 6480464 | CEBPB protein inhibits the reaction [Glucose results in decreased expression of ACE2 protein] more ... | CTD | PMID:28482072 and PMID:29266779 |
Cebpb | Mouse | all-trans-retinoic acid | affects localization | ISO | CEBPB (Homo sapiens) | 6480464 | Tretinoin affects the localization of CEBPB protein | CTD | PMID:16608438 |
Cebpb | Mouse | all-trans-retinoic acid | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Tretinoin results in increased expression of CEBPB mRNA and Tretinoin results in increased expression of CEBPB protein | CTD | PMID:14568882 and PMID:24977338 |
Cebpb | Mouse | all-trans-retinoic acid | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Tretinoin results in increased expression of CEBPB mRNA more ... | CTD | PMID:15498508 more ... |
Cebpb | Mouse | all-trans-retinoic acid | increases activity | ISO | CEBPB (Homo sapiens) | 6480464 | Tretinoin results in increased activity of CEBPB protein alternative form | CTD | PMID:16608438 |
Cebpb | Mouse | all-trans-retinoic acid | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | 2-bromopalmitate promotes the reaction [Tretinoin results in increased expression of CEBPB mRNA] more ... | CTD | PMID:15894607 more ... |
Cebpb | Mouse | alpha-linolenic acid | decreases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | alpha-Linolenic Acid results in decreased expression of CEBPB mRNA | CTD | PMID:14563831 |
Cebpb | Mouse | amiodarone | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Amiodarone results in increased expression of CEBPB mRNA | CTD | PMID:19774075 |
Cebpb | Mouse | amiodarone | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Amiodarone results in increased expression of CEBPB mRNA | CTD | PMID:25580480 |
Cebpb | Mouse | ammonium chloride | affects expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of CEBPB mRNA | CTD | PMID:16483693 |
Cebpb | Mouse | amphetamine | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Amphetamine results in increased expression of CEBPB mRNA | CTD | PMID:30779732 |
Cebpb | Mouse | andrographolide | multiple interactions | EXP | | 6480464 | andrographolide affects the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] affects the expression of CEBPB mRNA] and andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of and results in increased phosphorylation of CEBPB protein] | CTD | PMID:27475717 |
Cebpb | Mouse | anthra[1,9-cd]pyrazol-6(2H)-one | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | pyrazolanthrone inhibits the reaction [Calcitriol results in increased expression of CEBPB mRNA] more ... | CTD | PMID:14729647 and PMID:24376792 |
Cebpb | Mouse | antimony(0) | increases expression | EXP | | 6480464 | Antimony results in increased expression of CEBPB protein | CTD | PMID:37858840 |
Cebpb | Mouse | antimycin A | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Antimycin A results in increased expression of CEBPB mRNA | CTD | PMID:33512557 |
Cebpb | Mouse | apigenin | decreases expression | EXP | | 6480464 | Apigenin results in decreased expression of CEBPB mRNA | CTD | PMID:18359623 |
Cebpb | Mouse | aripiprazole | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [Aripiprazole co-treated with Ozone] results in increased expression of CEBPB mRNA | CTD | PMID:31476115 |
Cebpb | Mouse | aristolochic acid A | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of CEBPB mRNA | CTD | PMID:33212167 |
Cebpb | Mouse | arsane | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Arsenic results in decreased expression of CEBPB mRNA and Arsenic results in decreased expression of CEBPB protein | CTD | PMID:23108036 |
Cebpb | Mouse | arsane | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CEBPB mRNA more ... | CTD | PMID:23108036 more ... |
Cebpb | Mouse | arsenic atom | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CEBPB mRNA more ... | CTD | PMID:23108036 more ... |
Cebpb | Mouse | arsenic atom | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Arsenic results in decreased expression of CEBPB mRNA and Arsenic results in decreased expression of CEBPB protein | CTD | PMID:23108036 |
Cebpb | Mouse | arsenic trichloride | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [arsenic trichloride results in increased abundance of Arsenic] promotes the reaction [HIF1A protein binds to CEBPB gene] more ... | CTD | PMID:35625704 |
Cebpb | Mouse | arsenite(3-) | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | arsenite promotes the reaction [CEBPB protein binds to DDIT4 promoter] | CTD | PMID:16008523 |
Cebpb | Mouse | arsenite(3-) | multiple interactions | EXP | | 6480464 | TRP53 protein affects the reaction [arsenite results in decreased expression of CEBPB mRNA] | CTD | PMID:18929588 |
Cebpb | Mouse | arsenite(3-) | decreases expression | EXP | | 6480464 | arsenite results in decreased expression of CEBPB mRNA | CTD | PMID:18929588 |
Cebpb | Mouse | arsenite(3-) | increases activity | ISO | CEBPB (Homo sapiens) | 6480464 | arsenite results in increased activity of CEBPB protein | CTD | PMID:16008523 |
Cebpb | Mouse | arsenous acid | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of CEBPB mRNA | CTD | PMID:20471514 |
Cebpb | Mouse | arsenous acid | decreases methylation | ISO | CEBPB (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased methylation of CEBPB promoter | CTD | PMID:26046465 |
Cebpb | Mouse | arsenous acid | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CEBPB mRNA more ... | CTD | PMID:15894607 more ... |
Cebpb | Mouse | arsenous acid | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of CEBPB mRNA and Arsenic Trioxide results in increased expression of CEBPB protein | CTD | PMID:19690170 more ... |
Cebpb | Mouse | astemizole | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Astemizole results in increased expression of CEBPB mRNA | CTD | PMID:20221588 |
Cebpb | Mouse | atrazine | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | [Atrazine co-treated with Colforsin] results in increased expression of CEBPB protein and Atrazine promotes the reaction [FSHB protein results in increased expression of CEBPB protein] | CTD | PMID:25253736 |
Cebpb | Mouse | atrazine | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Atrazine results in increased expression of CEBPB mRNA | CTD | PMID:22378314 |
Cebpb | Mouse | Azaspiracid | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | azaspiracid results in increased expression of CEBPB mRNA | CTD | PMID:28939011 |
Cebpb | Mouse | azoxystrobin | affects expression | ISO | CEBPB (Homo sapiens) | 6480464 | azoxystrobin affects the expression of CEBPB mRNA | CTD | PMID:33512557 |
Cebpb | Mouse | baicalein | decreases expression | EXP | | 6480464 | baicalein results in decreased expression of CEBPB mRNA | CTD | PMID:24560969 |
Cebpb | Mouse | beauvericin | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [beauvericin co-treated with enniatins] results in decreased expression of CEBPB mRNA | CTD | PMID:31100301 |
Cebpb | Mouse | bellidifolin | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | bellidifolin results in decreased expression of CEBPB mRNA | CTD | PMID:33299414 |
Cebpb | Mouse | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CEBPB mRNA | CTD | PMID:22228805 and PMID:27195522 |
Cebpb | Mouse | benzo[a]pyrene | increases methylation | ISO | CEBPB (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of CEBPB promoter | CTD | PMID:27901495 |
Cebpb | Mouse | benzo[a]pyrene | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Benzo(a)pyrene metabolite results in decreased expression of CEBPB mRNA and Benzo(a)pyrene results in decreased expression of CEBPB mRNA | CTD | PMID:24356939 and PMID:32234424 |
Cebpb | Mouse | benzo[a]pyrene | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of CEBPB protein | CTD | PMID:32717239 |
Cebpb | Mouse | benzo[a]pyrene diol epoxide I | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 and PMID:20018196 |
Cebpb | Mouse | berberine | affects phosphorylation | EXP | | 6480464 | Berberine affects the phosphorylation of CEBPB protein | CTD | PMID:28038998 |
Cebpb | Mouse | berberine | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Berberine results in increased expression of CEBPB mRNA | CTD | PMID:28038998 |
Cebpb | Mouse | berberine | affects phosphorylation | ISO | CEBPB (Homo sapiens) | 6480464 | Berberine affects the phosphorylation of CEBPB protein | CTD | PMID:28038998 |
Cebpb | Mouse | berberine | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Berberine results in increased phosphorylation of CEBPB protein] and CEBPB protein promotes the reaction [Berberine results in increased expression of CD36 mRNA] | CTD | PMID:28038998 |
Cebpb | Mouse | beta-lapachone | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | beta-lapachone results in increased expression of CEBPB mRNA | CTD | PMID:38218311 |
Cebpb | Mouse | betulinic acid | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Betulinic Acid results in decreased expression of CEBPB protein modified form | CTD | PMID:30482226 |
Cebpb | Mouse | betulinic acid | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | Betulinic Acid inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of CEBPB protein alternative form] and Betulinic Acid inhibits the reaction [Bortezomib results in increased expression of CEBPB protein alternative form] | CTD | PMID:30482226 |
Cebpb | Mouse | betulinic acid | multiple interactions | EXP | | 6480464 | Betulinic Acid inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of CEBPB protein alternative form] and Betulinic Acid inhibits the reaction [Bortezomib results in increased expression of CEBPB protein alternative form] | CTD | PMID:30482226 |
Cebpb | Mouse | bifenthrin | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | bifenthrin inhibits the reaction [CGA protein results in increased expression of CEBPB mRNA] | CTD | PMID:21251947 |
Cebpb | Mouse | bis(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with 2 more ... | CTD | PMID:28433925 and PMID:38008054 |
Cebpb | Mouse | bis(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased expression of CEBPB mRNA and Diethylhexyl Phthalate results in decreased expression of CEBPB protein | CTD | PMID:33754040 and PMID:38008054 |
Cebpb | Mouse | bis(2-ethylhexyl) phthalate | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in increased expression of CEBPB mRNA | CTD | PMID:31163220 |
Cebpb | Mouse | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CEBPB mRNA | CTD | PMID:18359623 |
Cebpb | Mouse | bisphenol A | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [Vitamin D co-treated with bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CEBPB mRNA | CTD | PMID:33836827 |
Cebpb | Mouse | bisphenol A | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of CEBPB mRNA | CTD | PMID:32387340 |
Cebpb | Mouse | bisphenol A | affects expression | ISO | CEBPB (Homo sapiens) | 6480464 | bisphenol A affects the expression of CEBPB mRNA | CTD | PMID:30903817 |
Cebpb | Mouse | bisphenol A | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of CEBPB mRNA | CTD | PMID:25181051 more ... |
Cebpb | Mouse | bisphenol A | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | bisphenol A inhibits the reaction [CEBPB protein binds to CPT1A promoter] | CTD | PMID:25748669 |
Cebpb | Mouse | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CEBPB mRNA | CTD | PMID:26063408 and PMID:35598803 |
Cebpb | Mouse | bisphenol A | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with 2 more ... | CTD | PMID:25068083 and PMID:28433925 |
Cebpb | Mouse | bisphenol A | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | bisphenol A analog results in increased expression of CEBPB mRNA more ... | CTD | PMID:24418828 more ... |
Cebpb | Mouse | Bisphenol B | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | bisphenol B results in decreased expression of CEBPB mRNA | CTD | PMID:32387340 |
Cebpb | Mouse | bisphenol F | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CEBPB mRNA | CTD | PMID:28628672 |
Cebpb | Mouse | bisphenol F | decreases expression | EXP | | 6480464 | bisphenol F results in decreased expression of CEBPB mRNA | CTD | PMID:38685157 |
Cebpb | Mouse | bleomycin A2 | increases expression | EXP | | 6480464 | Bleomycin results in increased expression of CEBPB mRNA | CTD | PMID:17177178 |
Cebpb | Mouse | bleomycin A2 | increases response to substance | EXP | | 6480464 | CEBPB protein results in increased susceptibility to Bleomycin | CTD | PMID:21998664 |
Cebpb | Mouse | bleomycin A2 | multiple interactions | EXP | | 6480464 | CEBPB protein affects the reaction [Bleomycin results in increased expression of ACTA2 mRNA] more ... | CTD | PMID:17177178 |
Cebpb | Mouse | bleomycin A2 | decreases response to substance | EXP | | 6480464 | CEBPB gene mutant form results in decreased susceptibility to Bleomycin | CTD | PMID:17177178 |
Cebpb | Mouse | boric acid | multiple interactions | EXP | | 6480464 | boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPB mRNA] | CTD | PMID:28285642 |
Cebpb | Mouse | bortezomib | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | 1 more ... | CTD | PMID:20471514 and PMID:30482226 |
Cebpb | Mouse | bortezomib | multiple interactions | EXP | | 6480464 | 1 more ... | CTD | PMID:30482226 |
Cebpb | Mouse | bortezomib | increases expression | EXP | | 6480464 | Bortezomib results in increased expression of CEBPB protein alternative form | CTD | PMID:30482226 |
Cebpb | Mouse | bortezomib | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Bortezomib results in increased expression of CEBPB protein alternative form | CTD | PMID:30482226 |
Cebpb | Mouse | bortezomib | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Bortezomib results in increased expression of CEBPB protein | CTD | PMID:20830808 |
Cebpb | Mouse | bortezomib | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Bortezomib results in decreased expression of CEBPB mRNA | CTD | PMID:20471514 |
Cebpb | Mouse | bucladesine | increases expression | EXP | | 6480464 | Bucladesine results in increased expression of CEBPB protein | CTD | PMID:19282384 and PMID:19698295 |
Cebpb | Mouse | bucladesine | multiple interactions | EXP | | 6480464 | Tetradecanoylphorbol Acetate promotes the reaction [Bucladesine results in increased expression of CEBPB protein] | CTD | PMID:19282384 |
Cebpb | Mouse | butylated hydroxyanisole | multiple interactions | EXP | | 6480464 | Butylated Hydroxyanisole inhibits the reaction [LHB protein results in increased abundance of CEBPB mRNA] | CTD | PMID:21220312 |
Cebpb | Mouse | C60 fullerene | decreases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | fullerene C60 results in decreased expression of CEBPB mRNA | CTD | PMID:19167457 |
Cebpb | Mouse | cadmium dichloride | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of CEBPB mRNA | CTD | PMID:38568856 |
Cebpb | Mouse | caffeine | decreases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Caffeine results in decreased expression of CEBPB mRNA | CTD | PMID:30528684 |
Cebpb | Mouse | caffeine | increases phosphorylation | ISO | CEBPB (Homo sapiens) | 6480464 | Caffeine results in increased phosphorylation of CEBPB protein | CTD | PMID:35688186 |
Cebpb | Mouse | calcitriol | decreases expression | EXP | | 6480464 | Calcitriol results in decreased expression of CEBPB mRNA and Calcitriol results in decreased expression of CEBPB protein | CTD | PMID:16467308 |
Cebpb | Mouse | calcitriol | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Calcitriol results in increased expression of CEBPB mRNA and Calcitriol results in increased expression of CEBPB protein | CTD | PMID:14729647 more ... |
Cebpb | Mouse | calcitriol | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol results in increased expression of CEBPB mRNA] more ... | CTD | PMID:14729647 more ... |
Cebpb | Mouse | calcitriol | multiple interactions | EXP | | 6480464 | [Calcitriol results in increased expression of RUNX1T1 protein] which results in decreased activity of CEBPB protein | CTD | PMID:16467308 |
Cebpb | Mouse | calcium atom | affects expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Calcium affects the expression of CEBPB mRNA | CTD | PMID:15913539 |
Cebpb | Mouse | calcium(0) | affects expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Calcium affects the expression of CEBPB mRNA | CTD | PMID:15913539 |
Cebpb | Mouse | cannabidiol | increases expression | EXP | | 6480464 | Cannabidiol results in increased expression of CEBPB mRNA | CTD | PMID:30742662 |
Cebpb | Mouse | cannabidiol | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Cannabidiol results in increased expression of CEBPB mRNA | CTD | PMID:33244087 |
Cebpb | Mouse | cannabidiol | multiple interactions | EXP | | 6480464 | [lipopolysaccharide and E coli O55-B5 co-treated with Cannabidiol] results in increased expression of CEBPB mRNA | CTD | PMID:30742662 |
Cebpb | Mouse | capsaicin | multiple interactions | EXP | | 6480464 | [Capsaicin results in increased activity of CEBPB protein] inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 mRNA] and [Capsaicin results in increased activity of CEBPB protein] inhibits the reaction [Methylcholanthrene results in increased expression of CYP1A1 protein] | CTD | PMID:21250977 |
Cebpb | Mouse | capsaicin | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [CEBPB protein binds to GDF15 promoter] promotes the reaction [Capsaicin results in increased expression of GDF15 mRNA] more ... | CTD | PMID:20110283 |
Cebpb | Mouse | capsaicin | increases activity | EXP | | 6480464 | Capsaicin results in increased activity of CEBPB protein | CTD | PMID:21250977 |
Cebpb | Mouse | carbamazepine | affects expression | ISO | CEBPB (Homo sapiens) | 6480464 | Carbamazepine affects the expression of CEBPB mRNA | CTD | PMID:24752500 and PMID:25979313 |
Cebpb | Mouse | carbon nanotube | increases expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25554681 and PMID:25620056 |
Cebpb | Mouse | carbon nanotube | affects expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:23845593 and PMID:25554681 |
Cebpb | Mouse | carboxy-PTIO | multiple interactions | EXP | | 6480464 | 1 more ... | CTD | PMID:30482226 |
Cebpb | Mouse | carboxy-PTIO | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | 1 more ... | CTD | PMID:30482226 |
Cebpb | Mouse | carmustine | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Carmustine results in decreased expression of CEBPB mRNA | CTD | PMID:15980968 |
Cebpb | Mouse | ceruletide | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | [Dietary Fats co-treated with Ceruletide] results in increased expression of CEBPB protein more ... | CTD | PMID:26873426 |
Cebpb | Mouse | ceruletide | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Ceruletide results in increased expression of CEBPB mRNA | CTD | PMID:26873426 |
Cebpb | Mouse | chloropicrin | affects expression | ISO | CEBPB (Homo sapiens) | 6480464 | chloropicrin affects the expression of CEBPB mRNA | CTD | PMID:26352163 |
Cebpb | Mouse | chloroprene | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Chloroprene results in increased expression of CEBPB mRNA | CTD | PMID:23125180 |
Cebpb | Mouse | chloroquine | increases expression | EXP | | 6480464 | Chloroquine results in increased expression of CEBPB protein alternative form | CTD | PMID:30482226 |
Cebpb | Mouse | chloroquine | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | 1 more ... | CTD | PMID:30482226 |
Cebpb | Mouse | chloroquine | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Chloroquine results in increased expression of CEBPB protein alternative form | CTD | PMID:30482226 |
Cebpb | Mouse | chloroquine | multiple interactions | EXP | | 6480464 | 1 more ... | CTD | PMID:30482226 |
Cebpb | Mouse | chlorpyrifos | increases expression | EXP | | 6480464 | Chlorpyrifos results in increased expression of CEBPB mRNA | CTD | PMID:37019170 |
Cebpb | Mouse | choline | multiple interactions | EXP | | 6480464 | [[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MIR155 mRNA] which results in decreased expression of CEBPB protein more ... | CTD | PMID:20548288 more ... |
Cebpb | Mouse | choline | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of CEBPB mRNA] more ... | CTD | PMID:25712622 |
Cebpb | Mouse | Chorionic gonadotropin | multiple interactions | EXP | | 6480464 | [Gonadotropins and Equine co-treated with Chorionic Gonadotropin] results in increased expression of CEBPB mRNA | CTD | PMID:15831568 |
Cebpb | Mouse | ciglitazone | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | ciglitazone results in increased expression of CEBPB mRNA | CTD | PMID:22193206 |
Cebpb | Mouse | ciguatoxin CTX1B | affects expression | EXP | | 6480464 | Ciguatoxins affects the expression of CEBPB mRNA | CTD | PMID:18353800 |
Cebpb | Mouse | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of CEBPB mRNA | CTD | PMID:21151649 |
Cebpb | Mouse | cisplatin | affects expression | ISO | CEBPB (Homo sapiens) | 6480464 | Cisplatin affects the expression of CEBPB mRNA | CTD | PMID:23300844 |
Cebpb | Mouse | cisplatin | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Cisplatin results in increased expression of CEBPB mRNA | CTD | PMID:27594783 |
Cebpb | Mouse | cisplatin | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | Cisplatin promotes the reaction [Piroxicam results in increased expression of CEBPB mRNA] | CTD | PMID:21858171 |
Cebpb | Mouse | clofibrate | multiple interactions | EXP | | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of CEBPB mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CEBPB mRNA] | CTD | PMID:17585979 |
Cebpb | Mouse | clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of CEBPB mRNA | CTD | PMID:17585979 |
Cebpb | Mouse | cobalt dichloride | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | cobaltous chloride results in increased expression of CEBPB mRNA | CTD | PMID:22941251 |
Cebpb | Mouse | cobalt dichloride | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of CEBPB protein | CTD | PMID:29673971 |
Cebpb | Mouse | colforsin daropate hydrochloride | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | [Atrazine co-treated with Colforsin] results in increased expression of CEBPB protein | CTD | PMID:25253736 |
Cebpb | Mouse | colforsin daropate hydrochloride | increases expression | EXP | | 6480464 | Colforsin results in increased expression of CEBPB mRNA | CTD | PMID:14684744 |
Cebpb | Mouse | copper atom | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of CEBPB mRNA | CTD | PMID:20971185 |
Cebpb | Mouse | copper atom | decreases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Copper results in decreased expression of CEBPB mRNA | CTD | PMID:30556269 |
Cebpb | Mouse | copper(0) | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of CEBPB mRNA | CTD | PMID:20971185 |
Cebpb | Mouse | copper(0) | decreases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Copper results in decreased expression of CEBPB mRNA | CTD | PMID:30556269 |
Cebpb | Mouse | copper(II) chloride | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | cupric chloride results in increased expression of CEBPB mRNA | CTD | PMID:38568856 |
Cebpb | Mouse | copper(II) sulfate | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of CEBPB mRNA | CTD | PMID:19549813 |
Cebpb | Mouse | cordycepin | decreases expression | EXP | | 6480464 | cordycepin results in decreased expression of CEBPB mRNA and cordycepin results in decreased expression of CEBPB protein | CTD | PMID:22537056 |
Cebpb | Mouse | cordycepin | multiple interactions | EXP | | 6480464 | 4-nitrobenzylthioinosine inhibits the reaction [cordycepin results in decreased expression of CEBPB mRNA] | CTD | PMID:22537056 |
Cebpb | Mouse | corosolic acid | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | corosolic acid results in increased expression of CEBPB mRNA | CTD | PMID:37939859 |
Cebpb | Mouse | corticosterone | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Corticosterone results in increased expression of CEBPB mRNA | CTD | PMID:15755911 |
Cebpb | Mouse | corticosterone | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | CEBPB protein affects the reaction [Corticosterone results in increased expression of PTGS2 mRNA] more ... | CTD | PMID:18650268 |
Cebpb | Mouse | cortisol | affects expression | ISO | CEBPB (Homo sapiens) | 6480464 | Hydrocortisone affects the expression of CEBPB mRNA | CTD | PMID:30528684 |
Cebpb | Mouse | cortisol | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | Mifepristone affects the reaction [Hydrocortisone affects the expression of CEBPB mRNA] | CTD | PMID:30528684 |
Cebpb | Mouse | crocidolite asbestos | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | Asbestos more ... | CTD | PMID:8969274 and PMID:9378980 |
Cebpb | Mouse | Cuprizon | decreases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Cuprizone results in decreased expression of CEBPB mRNA | CTD | PMID:26577399 |
Cebpb | Mouse | curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CEBPB mRNA] | CTD | PMID:18200517 |
Cebpb | Mouse | cyclophosphamide | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Cyclophosphamide metabolite results in decreased expression of CEBPB mRNA | CTD | PMID:24356939 |
Cebpb | Mouse | cyclosporin A | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of CEBPB mRNA | CTD | PMID:20106945 more ... |
Cebpb | Mouse | D-glucose | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | CEBPB protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein] more ... | CTD | PMID:24376792 |
Cebpb | Mouse | D-glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of CEBPB protein | CTD | PMID:29266779 |
Cebpb | Mouse | D-glucose | multiple interactions | EXP | | 6480464 | CEBPB protein inhibits the reaction [Glucose results in decreased expression of ACE2 protein] more ... | CTD | PMID:28482072 and PMID:29266779 |
Cebpb | Mouse | DDE | decreases activity | ISO | CEBPB (Homo sapiens) | 6480464 | Dichlorodiphenyl Dichloroethylene results in decreased activity of CEBPB protein | CTD | PMID:27589886 |
Cebpb | Mouse | deguelin | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | deguelin results in increased expression of CEBPB mRNA | CTD | PMID:33512557 |
Cebpb | Mouse | deoxycholic acid | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Deoxycholic Acid results in increased expression of CEBPB | CTD | PMID:18444174 |
Cebpb | Mouse | deoxycholic acid | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | NRAS affects the reaction [Deoxycholic Acid results in increased expression of CEBPB] and Ursodeoxycholic Acid inhibits the reaction [Deoxycholic Acid results in increased expression of CEBPB] | CTD | PMID:18444174 |
Cebpb | Mouse | deoxynivalenol | multiple interactions | EXP | | 6480464 | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3 and 4-d)pyrimidine inhibits the reaction [deoxynivalenol results in increased activity of CEBPB protein] | CTD | PMID:15772366 |
Cebpb | Mouse | deoxynivalenol | increases activity | EXP | | 6480464 | deoxynivalenol results in increased activity of CEBPB protein | CTD | PMID:15772366 |
Cebpb | Mouse | deoxynivalenol | affects localization | EXP | | 6480464 | deoxynivalenol affects the localization of CEBPB protein | CTD | PMID:12604842 |
Cebpb | Mouse | dexamethasone | multiple interactions | EXP | | 6480464 | 14-deoxy-11 more ... | CTD | PMID:16054899 more ... |
Cebpb | Mouse | dexamethasone | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CEBPB mRNA and [Vitamin D co-treated with bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CEBPB mRNA | CTD | PMID:28628672 and PMID:33836827 |
Cebpb | Mouse | dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of CEBPB mRNA | CTD | PMID:21041162 and PMID:22733784 |
Cebpb | Mouse | dexamethasone | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Dexamethasone results in increased expression of CEBPB mRNA and Dexamethasone results in increased expression of CEBPB protein | CTD | PMID:14568882 more ... |
Cebpb | Mouse | dexamethasone | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | 2-amino-4-(3 more ... | CTD | PMID:15661831 more ... |
Cebpb | Mouse | diallyl trisulfide | multiple interactions | EXP | | 6480464 | [diallyl trisulfide results in decreased expression of [CEBPA protein co-treated with CEBPB protein co-treated with PPARG protein]] which results in decreased expression of FASN more ... | CTD | PMID:22137902 |
Cebpb | Mouse | diallyl trisulfide | decreases expression | EXP | | 6480464 | diallyl trisulfide results in decreased expression of CEBPB mRNA and diallyl trisulfide results in decreased expression of CEBPB protein | CTD | PMID:22137902 |
Cebpb | Mouse | diarsenic trioxide | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of CEBPB mRNA and Arsenic Trioxide results in increased expression of CEBPB protein | CTD | PMID:19690170 more ... |
Cebpb | Mouse | diarsenic trioxide | decreases methylation | ISO | CEBPB (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased methylation of CEBPB promoter | CTD | PMID:26046465 |
Cebpb | Mouse | diarsenic trioxide | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of CEBPB mRNA | CTD | PMID:20471514 |
Cebpb | Mouse | diarsenic trioxide | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CEBPB mRNA more ... | CTD | PMID:15894607 more ... |
Cebpb | Mouse | diazinon | affects expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Diazinon affects the expression of CEBPB mRNA | CTD | PMID:22546817 |
Cebpb | Mouse | dibenz[a,h]anthracene | decreases expression | EXP | | 6480464 | 1 more ... | CTD | PMID:26377693 |
Cebpb | Mouse | dibenziodolium | multiple interactions | EXP | | 6480464 | diphenyleneiodonium inhibits the reaction [Endosulfan results in increased expression of CEBPB protein] | CTD | PMID:25199686 |
Cebpb | Mouse | Dibutyl phosphate | affects expression | ISO | CEBPB (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of CEBPB mRNA | CTD | PMID:37042841 |
Cebpb | Mouse | dibutyl phthalate | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | Dibutyl Phthalate inhibits the reaction [CEBPB binds to CYP11A1 promoter] more ... | CTD | PMID:17884934 |
Cebpb | Mouse | dibutyl phthalate | decreases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Dibutyl Phthalate results in decreased expression of CEBPB mRNA and Dibutyl Phthalate results in decreased expression of CEBPB protein | CTD | PMID:15728792 more ... |
Cebpb | Mouse | dichloromethane | increases expression | EXP | | 6480464 | Methylene Chloride results in increased expression of CEBPB mRNA | CTD | PMID:28392392 |
Cebpb | Mouse | diclofenac | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Diclofenac results in increased expression of CEBPB mRNA | CTD | PMID:19022234 |
Cebpb | Mouse | diclofenac | affects expression | ISO | CEBPB (Homo sapiens) | 6480464 | Diclofenac affects the expression of CEBPB mRNA | CTD | PMID:24752500 |
Cebpb | Mouse | diclofenac | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Diclofenac results in increased expression of CEBPB mRNA | CTD | PMID:19022234 |
Cebpb | Mouse | dieldrin | affects expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Dieldrin affects the expression of CEBPB mRNA | CTD | PMID:22546817 |
Cebpb | Mouse | diethylstilbestrol | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Diethylstilbestrol results in increased expression of CEBPB mRNA | CTD | PMID:19371625 |
Cebpb | Mouse | diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of CEBPB mRNA | CTD | PMID:15289156 and PMID:21041162 |
Cebpb | Mouse | Diisodecyl phthalate | increases expression | EXP | | 6480464 | diisodecyl phthalate results in increased expression of CEBPB mRNA | CTD | PMID:29410257 |
Cebpb | Mouse | diisononyl phthalate | increases expression | EXP | | 6480464 | diisononyl phthalate results in increased expression of CEBPB mRNA | CTD | PMID:29410257 and PMID:31546122 |
Cebpb | Mouse | diisononyl phthalate | decreases expression | EXP | | 6480464 | diisononyl phthalate results in decreased expression of CEBPB mRNA | CTD | PMID:37482143 |
Cebpb | Mouse | dimethyl sulfoxide | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Dimethyl Sulfoxide results in increased expression of CEBPB mRNA | CTD | PMID:22193206 |
Cebpb | Mouse | dimethylarsinous acid | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | dimethylarsinous acid results in decreased expression of CEBPB mRNA | CTD | PMID:16507463 |
Cebpb | Mouse | dimethylarsinous acid | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | dimethylarsinous acid results in increased expression of CEBPB mRNA | CTD | PMID:23487506 |
Cebpb | Mouse | dinophysistoxin 1 | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | dinophysistoxin 1 results in increased expression of CEBPB mRNA | CTD | PMID:28939011 |
Cebpb | Mouse | dioxygen | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Oxygen deficiency results in decreased expression of CEBPB mRNA | CTD | PMID:26516004 |
Cebpb | Mouse | dioxygen | multiple interactions | EXP | | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CEBPB mRNA | CTD | PMID:30529165 |
Cebpb | Mouse | diquat | increases expression | EXP | | 6480464 | Diquat results in increased expression of CEBPB mRNA | CTD | PMID:36851058 |
Cebpb | Mouse | diuron | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Diuron results in decreased expression of CEBPB mRNA | CTD | PMID:35967413 |
Cebpb | Mouse | dorsomorphin | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 |
Cebpb | Mouse | dorsomorphin | multiple interactions | EXP | | 6480464 | dorsomorphin inhibits the reaction [rotenoisin A inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPB protein]] | CTD | PMID:30446312 |
Cebpb | Mouse | doxorubicin | increases response to substance | ISO | CEBPB (Homo sapiens) | 6480464 | CEBPB results in increased susceptibility to Doxorubicin | CTD | PMID:9359698 |
Cebpb | Mouse | doxorubicin | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [CEBPB protein alternative form results in increased susceptibility to Doxorubicin] promotes the reaction [[Bortezomib co-treated with Chloroquine] results in increased expression of and affects the localization of CALR protein] more ... | CTD | PMID:30482226 |
Cebpb | Mouse | doxorubicin | multiple interactions | EXP | | 6480464 | Doxorubicin promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of CEBPB protein alternative form] more ... | CTD | PMID:30482226 |
Cebpb | Mouse | doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of CEBPB mRNA and Doxorubicin results in increased expression of CEBPB protein alternative form | CTD | PMID:25896364 and PMID:30482226 |
Cebpb | Mouse | doxorubicin | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of CEBPB mRNA and Doxorubicin results in increased expression of CEBPB protein alternative form | CTD | PMID:16001973 and PMID:30482226 |
Cebpb | Mouse | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of CEBPB protein | CTD | PMID:25199686 |
Cebpb | Mouse | endosulfan | multiple interactions | EXP | | 6480464 | diphenyleneiodonium inhibits the reaction [Endosulfan results in increased expression of CEBPB protein] | CTD | PMID:25199686 |
Cebpb | Mouse | endrin | increases expression | EXP | | 6480464 | Endrin results in increased expression of CEBPB mRNA | CTD | PMID:34801515 |
Cebpb | Mouse | enniatin | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [beauvericin co-treated with enniatins] results in decreased expression of CEBPB mRNA | CTD | PMID:31100301 |
Cebpb | Mouse | entinostat | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPB mRNA | CTD | PMID:27188386 |
Cebpb | Mouse | entinostat | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | entinostat results in increased expression of CEBPB mRNA | CTD | PMID:26272509 |
Cebpb | Mouse | ethanol | decreases expression | EXP | | 6480464 | Ethanol results in decreased expression of CEBPB mRNA | CTD | PMID:19167417 |
Cebpb | Mouse | ethanol | affects expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Ethanol affects the expression of CEBPB mRNA | CTD | PMID:26188107 |
Cebpb | Mouse | ethyl methanesulfonate | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of CEBPB mRNA | CTD | PMID:23649840 |
Cebpb | Mouse | fenamidone | increases expression | EXP | | 6480464 | fenamidone results in increased expression of CEBPB mRNA | CTD | PMID:27029645 |
Cebpb | Mouse | fenpyroximate | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | fenpyroximate results in increased expression of CEBPB mRNA | CTD | PMID:33512557 |
Cebpb | Mouse | flavone | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | flavone results in increased localization of and results in increased activity of CEBPB protein | CTD | PMID:12663507 |
Cebpb | Mouse | flavonoids | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Flavonoids results in increased expression of CEBPB mRNA | CTD | PMID:18035473 |
Cebpb | Mouse | fluoranthene | multiple interactions | EXP | | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in increased expression of CEBPB mRNA | CTD | PMID:28329830 |
Cebpb | Mouse | folic acid | multiple interactions | EXP | | 6480464 | [1 more ... | CTD | PMID:20548288 more ... |
Cebpb | Mouse | folic acid | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [Folic Acid deficiency co-treated with Methotrexate] results in increased expression of CEBPB mRNA | CTD | PMID:24657277 |
Cebpb | Mouse | folpet | increases expression | EXP | | 6480464 | folpet results in increased expression of CEBPB mRNA | CTD | PMID:31558096 |
Cebpb | Mouse | formaldehyde | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of CEBPB mRNA | CTD | PMID:23649840 |
Cebpb | Mouse | gallic acid | decreases expression | EXP | | 6480464 | Gallic Acid results in decreased expression of CEBPB protein | CTD | PMID:24036142 |
Cebpb | Mouse | gallocatechin | decreases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | gallocatechol results in decreased expression of CEBPB mRNA | CTD | PMID:21877759 |
Cebpb | Mouse | gamma-hexachlorocyclohexane | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Hexachlorocyclohexane results in increased expression of CEBPB mRNA | CTD | PMID:24356939 |
Cebpb | Mouse | geldanamycin | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | geldanamycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of [[CEBPB protein binds to CEBPB protein] which binds to PTGS2 promoter]] | CTD | PMID:11133817 |
Cebpb | Mouse | gemcitabine | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Gemcitabine results in increased expression of CEBPB mRNA | CTD | PMID:17039268 |
Cebpb | Mouse | gemfibrozil | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | Gemfibrozil inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased activity of CEBPB protein] | CTD | PMID:12244038 |
Cebpb | Mouse | genistein | multiple interactions | EXP | | 6480464 | Genistein inhibits the reaction [Lipopolysaccharides results in increased activity of CEBPB protein] | CTD | PMID:15832817 |
Cebpb | Mouse | genistein | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Genistein results in increased expression of CEBPB mRNA | CTD | PMID:24361872 |
Cebpb | Mouse | genistein | decreases expression | EXP | | 6480464 | Genistein results in decreased expression of CEBPB mRNA | CTD | PMID:18359623 and PMID:21048042 |
Cebpb | Mouse | genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of CEBPB mRNA | CTD | PMID:15289156 |
Cebpb | Mouse | genistein | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Genistein results in increased expression of CEBPB mRNA | CTD | PMID:19371625 |
Cebpb | Mouse | genistein 7-O-beta-D-glucoside | multiple interactions | EXP | | 6480464 | genistin inhibits the reaction [Lipopolysaccharides results in increased activity of CEBPB protein] | CTD | PMID:15832817 |
Cebpb | Mouse | geraniol | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | geraniol results in increased expression of CEBPB mRNA | CTD | PMID:27683099 |
Cebpb | Mouse | glucose | multiple interactions | EXP | | 6480464 | CEBPB protein inhibits the reaction [Glucose results in decreased expression of ACE2 protein] more ... | CTD | PMID:28482072 and PMID:29266779 |
Cebpb | Mouse | glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of CEBPB protein | CTD | PMID:29266779 |
Cebpb | Mouse | glucose | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | CEBPB protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein] more ... | CTD | PMID:24376792 |
Cebpb | Mouse | glutathione | multiple interactions | EXP | | 6480464 | Glutathione inhibits the reaction [LHB protein results in increased abundance of CEBPB mRNA] | CTD | PMID:21220312 |
Cebpb | Mouse | glycidol | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | glycidol results in increased expression of CEBPB mRNA | CTD | PMID:24915197 |
Cebpb | Mouse | glycidol | increases methylation | ISO | Cebpb (Rattus norvegicus) | 6480464 | glycidol results in increased methylation of CEBPB promoter | CTD | PMID:33150595 |
Cebpb | Mouse | glycidol | decreases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | glycidol results in decreased expression of CEBPB mRNA | CTD | PMID:33150645 |
Cebpb | Mouse | glycyrrhizinic acid | multiple interactions | EXP | | 6480464 | Glycyrrhizic Acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPB mRNA] | CTD | PMID:34302803 |
Cebpb | Mouse | GW 4064 | multiple interactions | EXP | | 6480464 | GW 4064 promotes the reaction [NR1H4 protein binds to CEBPB gene] | CTD | PMID:20091679 |
Cebpb | Mouse | herbimycin | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | herbimycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of [[CEBPA protein binds to CEBPB protein] which binds to PTGS2 promoter]] | CTD | PMID:11133817 |
Cebpb | Mouse | hexadecanoic acid | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | [Palmitic Acid co-treated with Sincalide] results in increased expression of CEBPB mRNA more ... | CTD | PMID:26873426 |
Cebpb | Mouse | Honokiol | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | honokiol results in decreased expression of CEBPB protein | CTD | PMID:34973135 |
Cebpb | Mouse | Honokiol | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | 4-phenylbutyric acid inhibits the reaction [honokiol results in decreased activity of CEBPB protein] more ... | CTD | PMID:34973135 |
Cebpb | Mouse | hydrogen peroxide | affects expression | ISO | CEBPB (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of CEBPB mRNA | CTD | PMID:20044591 |
Cebpb | Mouse | hydrogen peroxide | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | Hydrogen Peroxide promotes the reaction [CEBPB protein binds to IL6 promoter] and tetramethylthiourea inhibits the reaction [Hydrogen Peroxide promotes the reaction [CEBPB protein binds to IL6 promoter]] | CTD | PMID:9378980 |
Cebpb | Mouse | hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of CEBPB mRNA | CTD | PMID:21220312 |
Cebpb | Mouse | hydrogen peroxide | multiple interactions | EXP | | 6480464 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Hydrogen Peroxide results in increased expression of CEBPB mRNA] and U 0126 inhibits the reaction [Hydrogen Peroxide results in increased expression of CEBPB mRNA] | CTD | PMID:21220312 |
Cebpb | Mouse | Indeno[1,2,3-cd]pyrene | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | indeno(1 more ... | CTD | PMID:32251684 |
Cebpb | Mouse | indirubin | multiple interactions | EXP | | 6480464 | [indirubin co-treated with tanshinone] promotes the reaction [tetraarsenic tetrasulfide results in increased expression of CEBPB protein] and [indirubin co-treated with tetraarsenic tetrasulfide] promotes the reaction [tanshinone results in increased expression of CEBPB protein] | CTD | PMID:18344322 |
Cebpb | Mouse | indometacin | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CEBPB mRNA | CTD | PMID:28628672 |
Cebpb | Mouse | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of CEBPB mRNA more ... | CTD | PMID:33412187 |
Cebpb | Mouse | Iodine aqueous | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | Lugol's solution inhibits the reaction [potassium perchlorate results in decreased expression of CEBPB protein] | CTD | PMID:29673971 |
Cebpb | Mouse | iron dichloride | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | ferrous chloride results in decreased expression of CEBPB mRNA | CTD | PMID:35984750 |
Cebpb | Mouse | iron(2+) sulfate (anhydrous) | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | ferrous sulfate results in increased expression of CEBPB mRNA | CTD | PMID:19428942 |
Cebpb | Mouse | isoniazide | decreases expression | EXP | | 6480464 | Isoniazid results in decreased expression of CEBPB protein | CTD | PMID:24128855 |
Cebpb | Mouse | ketamine | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Ketamine results in increased expression of CEBPB mRNA | CTD | PMID:20080153 |
Cebpb | Mouse | L-ascorbic acid | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Ascorbic Acid results in increased expression of CEBPB mRNA | CTD | PMID:15372504 |
Cebpb | Mouse | L-methionine | multiple interactions | EXP | | 6480464 | [[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MIR155 mRNA] which results in decreased expression of CEBPB protein more ... | CTD | PMID:20548288 and PMID:25712622 |
Cebpb | Mouse | L-methionine | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of CEBPB mRNA] more ... | CTD | PMID:25712622 |
Cebpb | Mouse | L-serine | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Serine results in decreased expression of CEBPB mRNA | CTD | PMID:29098664 |
Cebpb | Mouse | lactacystin | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | lactacystin results in increased expression of CEBPB protein | CTD | PMID:11779194 |
Cebpb | Mouse | lactucin | multiple interactions | EXP | | 6480464 | lactucin affects the reaction [Dietary Fats affects the expression of CEBPB protein] | CTD | PMID:32023857 |
Cebpb | Mouse | lead diacetate | affects expression | EXP | | 6480464 | lead acetate affects the expression of CEBPB mRNA | CTD | PMID:21829687 |
Cebpb | Mouse | lead diacetate | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | lead acetate results in increased expression of CEBPB mRNA | CTD | PMID:38568856 |
Cebpb | Mouse | lead diacetate | increases expression | EXP | | 6480464 | lead acetate results in increased expression of CEBPB mRNA | CTD | PMID:25270620 |
Cebpb | Mouse | lead(0) | affects expression | ISO | CEBPB (Homo sapiens) | 6480464 | Lead affects the expression of CEBPB mRNA | CTD | PMID:22313790 |
Cebpb | Mouse | lead(0) | increases expression | EXP | | 6480464 | Lead results in increased expression of CEBPB | CTD | PMID:23086611 |
Cebpb | Mouse | leflunomide | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | leflunomide results in increased expression of CEBPB mRNA | CTD | PMID:24136188 |
Cebpb | Mouse | leflunomide | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | leflunomide results in increased expression of CEBPB mRNA | CTD | PMID:28988120 |
Cebpb | Mouse | levofloxacin | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Levofloxacin results in increased expression of CEBPB mRNA | CTD | PMID:24136188 |
Cebpb | Mouse | linalool | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | linalool results in increased expression of CEBPB mRNA | CTD | PMID:20536181 |
Cebpb | Mouse | lipopolysaccharide | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Lipopolysaccharides results in increased expression of CEBPB mRNA | CTD | PMID:21911040 |
Cebpb | Mouse | lipopolysaccharide | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Lipopolysaccharides results in increased expression of CEBPB mRNA and Lipopolysaccharides results in increased expression of CEBPB protein | CTD | PMID:11779202 more ... |
Cebpb | Mouse | lipopolysaccharide | increases expression | EXP | | 6480464 | Lipopolysaccharides results in increased expression of CEBPB mRNA and Lipopolysaccharides results in increased expression of CEBPB protein | CTD | PMID:17316017 and PMID:34952004 |
Cebpb | Mouse | lipopolysaccharide | increases activity | EXP | | 6480464 | Lipopolysaccharides results in increased activity of CEBPB protein | CTD | PMID:14670622 and PMID:15832817 |
Cebpb | Mouse | lipopolysaccharide | multiple interactions | EXP | | 6480464 | 3 more ... | CTD | PMID:15832817 more ... |
Cebpb | Mouse | lipopolysaccharide | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | trichostatin A inhibits the reaction [Lipopolysaccharides results in increased expression of CEBPB mRNA] | CTD | PMID:21911040 |
Cebpb | Mouse | LY294002 | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of CEBPB mRNA] | CTD | PMID:25712622 |
Cebpb | Mouse | manganese atom | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CEBPB mRNA and [manganese chloride results in increased abundance of Manganese] which results in increased expression of CEBPB mRNA | CTD | PMID:39836092 |
Cebpb | Mouse | manganese(0) | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CEBPB mRNA and [manganese chloride results in increased abundance of Manganese] which results in increased expression of CEBPB mRNA | CTD | PMID:39836092 |
Cebpb | Mouse | manganese(II) chloride | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CEBPB mRNA and [manganese chloride results in increased abundance of Manganese] which results in increased expression of CEBPB mRNA | CTD | PMID:39836092 |
Cebpb | Mouse | MeIQx | increases phosphorylation | ISO | CEBPB (Homo sapiens) | 6480464 | 2-amino-3 more ... | CTD | PMID:23208499 |
Cebpb | Mouse | MeIQx | affects response to substance | ISO | CEBPB (Homo sapiens) | 6480464 | CEBPB protein affects the susceptibility to 2-amino-3 more ... | CTD | PMID:23208499 |
Cebpb | Mouse | melatonin | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of CEBPB protein] | CTD | PMID:38008054 |
Cebpb | Mouse | melatonin | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | CEBPB protein inhibits the reaction [Melatonin results in decreased activity of HDAC3 protein] | CTD | PMID:34973135 |
Cebpb | Mouse | mercury dibromide | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | mercuric bromide results in increased expression of CEBPB mRNA | CTD | PMID:26272509 |
Cebpb | Mouse | mercury dibromide | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPB mRNA | CTD | PMID:27188386 |
Cebpb | Mouse | mercury dichloride | multiple interactions | EXP | | 6480464 | Mercuric Chloride results in increased expression of and results in increased activity of CEBPB protein | CTD | PMID:11267658 |
Cebpb | Mouse | mercury dichloride | increases stability | EXP | | 6480464 | Mercuric Chloride results in increased stability of CEBPB mRNA | CTD | PMID:11267658 |
Cebpb | Mouse | methamphetamine | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Methamphetamine results in increased expression of CEBPB mRNA and Methamphetamine results in increased expression of CEBPB protein | CTD | PMID:19564919 and PMID:31059759 |
Cebpb | Mouse | methamphetamine | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | CEBPB protein affects the reaction [Methamphetamine results in decreased expression of PRKN protein] and CEBPB protein affects the reaction [Methamphetamine results in increased expression of TRIB3 protein] | CTD | PMID:31059759 |
Cebpb | Mouse | methamphetamine | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | [Methamphetamine co-treated with SCH 23390] results in increased expression of CEBPB mRNA more ... | CTD | PMID:19564919 and PMID:31059759 |
Cebpb | Mouse | methotrexate | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Methotrexate results in increased expression of CEBPB mRNA | CTD | PMID:24657277 |
Cebpb | Mouse | methotrexate | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Methotrexate results in decreased expression of CEBPB mRNA | CTD | PMID:24449571 |
Cebpb | Mouse | methotrexate | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [Folic Acid deficiency co-treated with Methotrexate] results in increased expression of CEBPB mRNA | CTD | PMID:24657277 |
Cebpb | Mouse | methyl methanesulfonate | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of CEBPB mRNA | CTD | PMID:23649840 |
Cebpb | Mouse | Methylazoxymethanol acetate | decreases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Methylazoxymethanol Acetate results in decreased expression of CEBPB mRNA | CTD | PMID:28349193 |
Cebpb | Mouse | methylmercury chloride | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of CEBPB mRNA | CTD | PMID:23179753 more ... |
Cebpb | Mouse | methylmercury chloride | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of CEBPB mRNA | CTD | PMID:34089799 |
Cebpb | Mouse | methylmercury chloride | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPB mRNA | CTD | PMID:27188386 |
Cebpb | Mouse | metyrapone | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | [[Air Pollutants results in increased abundance of Ozone] which co-treated with Metyrapone] results in increased expression of CEBPB mRNA | CTD | PMID:37088303 |
Cebpb | Mouse | mifepristone | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | Mifepristone promotes the reaction [CEBPB protein binds to NR3C1 protein] | CTD | PMID:18650268 |
Cebpb | Mouse | mifepristone | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | Mifepristone affects the reaction [Hydrocortisone affects the expression of CEBPB mRNA] | CTD | PMID:30528684 |
Cebpb | Mouse | mono(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of CEBPB mRNA and mono-(2-ethylhexyl)phthalate results in increased expression of CEBPB protein | CTD | PMID:25543134 and PMID:33091777 |
Cebpb | Mouse | mono(2-ethylhexyl) phthalate | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of CEBPB mRNA | CTD | PMID:36695872 |
Cebpb | Mouse | Monobutylphthalate | decreases expression | EXP | | 6480464 | monobutyl phthalate results in decreased expression of CEBPB mRNA | CTD | PMID:35278568 |
Cebpb | Mouse | Muraglitazar | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | muraglitazar results in increased expression of CEBPB mRNA | CTD | PMID:21515302 |
Cebpb | Mouse | N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide | multiple interactions | EXP | | 6480464 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Hydrogen Peroxide results in increased expression of CEBPB mRNA] more ... | CTD | PMID:14684744 and PMID:21220312 |
Cebpb | Mouse | N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [LHB protein results in increased abundance of CEBPB mRNA] | CTD | PMID:21220312 |
Cebpb | Mouse | N-acetylsphingosine | decreases localization | ISO | Cebpb (Rattus norvegicus) | 6480464 | N-acetylsphingosine results in decreased localization of CEBPB protein | CTD | PMID:15319326 |
Cebpb | Mouse | N-acetylsphingosine | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [N-acetylsphingosine results in decreased localization of CEBPB protein] and N-acetylsphingosine inhibits the reaction [oltipraz results in increased localization of CEBPB protein] | CTD | PMID:15319326 |
Cebpb | Mouse | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of and results in increased localization of CEBPB protein and Quercetin inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of and results in increased localization of CEBPB protein] | CTD | PMID:11779194 |
Cebpb | Mouse | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [N-acetylsphingosine results in decreased localization of CEBPB protein] | CTD | PMID:15319326 |
Cebpb | Mouse | N-methyl-4-phenylpyridinium | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of CEBPB mRNA | CTD | PMID:24810058 |
Cebpb | Mouse | naphthalenes | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Naphthalenes results in increased expression of CEBPB protein | CTD | PMID:17337753 |
Cebpb | Mouse | nickel atom | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | 2-((aminocarbonyl)amino)-5-(4-fluorophenyl)-3-thiophenecarboxamide inhibits the reaction [[Nickel co-treated with lipopolysaccharide more ... | CTD | PMID:35623502 |
Cebpb | Mouse | nickel dichloride | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | nickel chloride results in increased expression of CEBPB mRNA | CTD | PMID:17312168 |
Cebpb | Mouse | nickel dichloride | affects expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | nickel chloride affects the expression of CEBPB mRNA | CTD | PMID:22546817 |
Cebpb | Mouse | niclosamide | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Niclosamide results in increased expression of CEBPB mRNA | CTD | PMID:36318118 |
Cebpb | Mouse | nicotine | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Nicotine results in increased expression of CEBPB mRNA | CTD | PMID:18805435 |
Cebpb | Mouse | nicotine | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | [Nicotine results in increased abundance of Cotinine] which results in increased expression of CEBPB mRNA | CTD | PMID:29617909 |
Cebpb | Mouse | nicotinic acid | decreases expression | EXP | | 6480464 | Niacin results in decreased expression of CEBPB mRNA and Niacin results in decreased expression of CEBPB protein | CTD | PMID:21236357 |
Cebpb | Mouse | nicotinic acid | multiple interactions | EXP | | 6480464 | [Niacin inhibits the reaction [CEBPB protein binds to PTGS2 promoter]] which results in decreased expression of PTGS2 mRNA and Niacin inhibits the reaction [CEBPB protein binds to PTGS2 promoter] | CTD | PMID:21236357 |
Cebpb | Mouse | nitroprusside | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Nitroprusside results in increased expression of CEBPB protein alternative form | CTD | PMID:30482226 |
Cebpb | Mouse | nitroprusside | increases expression | EXP | | 6480464 | Nitroprusside results in increased expression of CEBPB protein alternative form | CTD | PMID:30482226 |
Cebpb | Mouse | nitroprusside | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | 1 more ... | CTD | PMID:30482226 |
Cebpb | Mouse | nitroprusside | multiple interactions | EXP | | 6480464 | 1 more ... | CTD | PMID:30482226 |
Cebpb | Mouse | ochratoxin A | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | ochratoxin A metabolite results in decreased expression of CEBPB mRNA and ochratoxin A results in decreased expression of CEBPB mRNA | CTD | PMID:19287073 and PMID:24356939 |
Cebpb | Mouse | ochratoxin A | decreases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | ochratoxin A results in decreased expression of CEBPB mRNA | CTD | PMID:23358140 |
Cebpb | Mouse | okadaic acid | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Okadaic Acid results in increased expression of CEBPB mRNA | CTD | PMID:28939011 |
Cebpb | Mouse | oltipraz | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | [Dexamethasone co-treated with oltipraz] results in increased activity of CEBPB protein more ... | CTD | PMID:12509401 more ... |
Cebpb | Mouse | oxaliplatin | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | oxaliplatin results in increased expression of CEBPB mRNA | CTD | PMID:25729387 |
Cebpb | Mouse | oxaliplatin | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of CEBPB mRNA | CTD | PMID:25729387 |
Cebpb | Mouse | oxidopamine | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Oxidopamine results in increased expression of CEBPB mRNA | CTD | PMID:12486162 |
Cebpb | Mouse | ozone | increases activity | ISO | CEBPB (Homo sapiens) | 6480464 | Ozone results in increased activity of CEBPB protein | CTD | PMID:16819095 and PMID:9124608 |
Cebpb | Mouse | ozone | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | [[Air Pollutants results in increased abundance of Ozone] which co-treated with Metyrapone] results in increased expression of CEBPB mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CEBPB mRNA | CTD | PMID:37088303 |
Cebpb | Mouse | ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of CEBPB mRNA | CTD | PMID:26342085 |
Cebpb | Mouse | ozone | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of CEBPB mRNA and [Aripiprazole co-treated with Ozone] results in increased expression of CEBPB mRNA | CTD | PMID:31476115 and PMID:35430440 |
Cebpb | Mouse | ozone | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Ozone results in increased expression of CEBPB mRNA | CTD | PMID:31476115 |
Cebpb | Mouse | p-chloromercuribenzoic acid | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in increased expression of CEBPB mRNA | CTD | PMID:26272509 |
Cebpb | Mouse | p-chloromercuribenzoic acid | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPB mRNA | CTD | PMID:27188386 |
Cebpb | Mouse | panobinostat | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPB mRNA | CTD | PMID:27188386 |
Cebpb | Mouse | panobinostat | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | panobinostat results in increased expression of CEBPB mRNA | CTD | PMID:26272509 |
Cebpb | Mouse | paracetamol | multiple interactions | EXP | | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of CEBPB mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CEBPB mRNA] | CTD | PMID:17585979 |
Cebpb | Mouse | paracetamol | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of CEBPB mRNA | CTD | PMID:38614205 |
Cebpb | Mouse | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of CEBPB mRNA | CTD | PMID:17562736 |
Cebpb | Mouse | paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of CEBPB mRNA | CTD | PMID:12595580 and PMID:21463325 |
Cebpb | Mouse | paraquat | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Paraquat results in increased expression of CEBPB mRNA | CTD | PMID:23613995 |
Cebpb | Mouse | pentane | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | pentane results in decreased expression of CEBPB mRNA | CTD | PMID:33064461 |
Cebpb | Mouse | perfluorohexanesulfonic acid | decreases expression | EXP | | 6480464 | perfluorohexanesulfonic acid results in decreased expression of CEBPB mRNA | CTD | PMID:37995155 |
Cebpb | Mouse | PF-3758309 | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | PF 3758309 results in decreased expression of CEBPB mRNA | CTD | PMID:29048629 |
Cebpb | Mouse | phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of CEBPB mRNA | CTD | PMID:19270015 |
Cebpb | Mouse | phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of CEBPB mRNA | CTD | PMID:23091169 |
Cebpb | Mouse | phenobarbital | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Phenobarbital results in increased expression of CEBPB mRNA | CTD | PMID:19162173 |
Cebpb | Mouse | phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of CEBPB mRNA | CTD | PMID:19270015 |
Cebpb | Mouse | phenylmercury acetate | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of CEBPB mRNA | CTD | PMID:26272509 |
Cebpb | Mouse | phenylmercury acetate | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPB mRNA | CTD | PMID:27188386 |
Cebpb | Mouse | PhIP | increases phosphorylation | ISO | CEBPB (Homo sapiens) | 6480464 | 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine results in increased phosphorylation of CEBPB protein | CTD | PMID:23208499 |
Cebpb | Mouse | PhIP | affects response to substance | ISO | CEBPB (Homo sapiens) | 6480464 | CEBPB protein affects the susceptibility to 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine | CTD | PMID:23208499 |
Cebpb | Mouse | phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | Tetradecanoylphorbol Acetate promotes the reaction [Bucladesine results in increased expression of CEBPB protein] | CTD | PMID:19282384 |
Cebpb | Mouse | phorbol 13-acetate 12-myristate | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Tetradecanoylphorbol Acetate results in decreased expression of CEBPB mRNA | CTD | PMID:33268675 |
Cebpb | Mouse | phorone | affects expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | phorone affects the expression of CEBPB mRNA | CTD | PMID:18198479 |
Cebpb | Mouse | picene | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | picene results in decreased expression of CEBPB mRNA | CTD | PMID:32251684 |
Cebpb | Mouse | pinostrobin | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | pinostrobin results in increased expression of CEBPB mRNA | CTD | PMID:37777166 |
Cebpb | Mouse | pirinixic acid | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | pirinixic acid results in increased expression of CEBPB mRNA | CTD | PMID:19162173 |
Cebpb | Mouse | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of CEBPB mRNA | CTD | PMID:18301758 and PMID:18445702 |
Cebpb | Mouse | piroxicam | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | Cisplatin promotes the reaction [Piroxicam results in increased expression of CEBPB mRNA] | CTD | PMID:21858171 |
Cebpb | Mouse | piroxicam | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Piroxicam results in decreased expression of CEBPB mRNA | CTD | PMID:21858171 |
Cebpb | Mouse | pregnenolone 16alpha-carbonitrile | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Pregnenolone Carbonitrile results in increased expression of CEBPB mRNA | CTD | PMID:19162173 |
Cebpb | Mouse | pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of CEBPB mRNA | CTD | PMID:28903501 |
Cebpb | Mouse | progesterone | increases response to substance | EXP | | 6480464 | CEBPB protein results in increased susceptibility to Progesterone | CTD | PMID:23097472 |
Cebpb | Mouse | progesterone | decreases expression | EXP | | 6480464 | Progesterone results in decreased expression of CEBPB mRNA | CTD | PMID:21549006 |
Cebpb | Mouse | progesterone | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Progesterone results in increased expression of CEBPB mRNA | CTD | PMID:20726854 |
Cebpb | Mouse | prostaglandin J2 | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | [9-deoxy-delta-9-prostaglandin D2 co-treated with alitretinoin] results in increased activity of CEBPB protein | CTD | PMID:15150131 |
Cebpb | Mouse | pyrazinecarboxamide | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Pyrazinamide results in increased expression of CEBPB mRNA | CTD | PMID:22431067 |
Cebpb | Mouse | pyrimidifen | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | pyrimidifen results in increased expression of CEBPB mRNA | CTD | PMID:33512557 |
Cebpb | Mouse | pyrrolidine dithiocarbamate | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | pyrrolidine dithiocarbamic acid promotes the reaction [CEBPB protein binds to LCMT2 promoter] | CTD | PMID:9359698 |
Cebpb | Mouse | pyrrolidine dithiocarbamate | increases response to substance | ISO | CEBPB (Homo sapiens) | 6480464 | CEBPB results in increased susceptibility to pyrrolidine dithiocarbamic acid | CTD | PMID:9359698 |
Cebpb | Mouse | quercetin | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | Quercetin inhibits the reaction [[Dietary Fats co-treated with Ceruletide] results in increased expression of CEBPB protein] more ... | CTD | PMID:20501703 and PMID:26873426 |
Cebpb | Mouse | quercetin | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Quercetin results in increased expression of CEBPB mRNA and Quercetin results in increased expression of CEBPB protein | CTD | PMID:20501703 |
Cebpb | Mouse | quercetin | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | Quercetin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of CEBPB mRNA] more ... | CTD | PMID:11779194 more ... |
Cebpb | Mouse | quercetin | affects binding | ISO | CEBPB (Homo sapiens) | 6480464 | Quercetin binds to CEBPB protein | CTD | PMID:25875015 |
Cebpb | Mouse | quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of CEBPB mRNA] | CTD | PMID:25712622 |
Cebpb | Mouse | raloxifene | affects expression | ISO | CEBPB (Homo sapiens) | 6480464 | Raloxifene Hydrochloride affects the expression of CEBPB mRNA | CTD | PMID:14699072 |
Cebpb | Mouse | raloxifene | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Raloxifene Hydrochloride results in increased expression of CEBPB mRNA | CTD | PMID:16497877 |
Cebpb | Mouse | raloxifene | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of CEBPB mRNA | CTD | PMID:19059307 |
Cebpb | Mouse | reactive oxygen species | affects expression | ISO | CEBPB (Homo sapiens) | 6480464 | Reactive Oxygen Species affects the expression of CEBPB mRNA | CTD | PMID:25800948 |
Cebpb | Mouse | resveratrol | decreases expression | EXP | | 6480464 | resveratrol metabolite results in decreased expression of CEBPB mRNA more ... | CTD | PMID:22945685 more ... |
Cebpb | Mouse | resveratrol | multiple interactions | EXP | | 6480464 | resveratrol promotes the reaction [Lipopolysaccharides results in increased expression of CEBPB protein] | CTD | PMID:17316017 |
Cebpb | Mouse | riboflavin | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Riboflavin deficiency results in increased expression of CEBPB mRNA and Riboflavin deficiency results in increased expression of CEBPB protein | CTD | PMID:16856317 |
Cebpb | Mouse | rifampicin | multiple interactions | EXP | | 6480464 | [Rifampin affects the susceptibility to Dietary Fats] which results in decreased expression of CEBPB mRNA more ... | CTD | PMID:33412187 |
Cebpb | Mouse | rolipram | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | Rolipram promotes the reaction [FSHB protein results in increased expression of CEBPB protein] | CTD | PMID:25253736 |
Cebpb | Mouse | rotenone | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Rotenone results in increased expression of CEBPB mRNA | CTD | PMID:29955902 |
Cebpb | Mouse | rotenone | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Rotenone results in increased expression of CEBPB mRNA | CTD | PMID:32115830 |
Cebpb | Mouse | rotenone | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | troxerutin inhibits the reaction [Rotenone results in increased expression of CEBPB mRNA] | CTD | PMID:32115830 |
Cebpb | Mouse | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of CEBPB mRNA | CTD | PMID:23186747 |
Cebpb | Mouse | rotenone | multiple interactions | EXP | | 6480464 | CEBPB protein affects the reaction [Rotenone results in increased expression of GSTA1 mRNA] and CEBPB protein affects the reaction [Rotenone results in increased expression of TRIB3 mRNA] | CTD | PMID:19304788 |
Cebpb | Mouse | S-(1,2-dichlorovinyl)-L-cysteine | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | S-(1 and 2-dichlorovinyl)cysteine results in increased expression of CEBPB mRNA | CTD | PMID:33725128 and PMID:36576512 |
Cebpb | Mouse | SB 203580 | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | SB 203580 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPB protein] and SB 203580 inhibits the reaction [IFNG protein results in increased phosphorylation of CEBPB protein] | CTD | PMID:16355272 and PMID:24376792 |
Cebpb | Mouse | SB 431542 | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 |
Cebpb | Mouse | SCH 23390 | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | [Methamphetamine co-treated with SCH 23390] results in increased expression of CEBPB mRNA | CTD | PMID:19564919 |
Cebpb | Mouse | sevoflurane | affects expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | sevoflurane affects the expression of CEBPB mRNA | CTD | PMID:15967596 |
Cebpb | Mouse | sildenafil citrate | multiple interactions | EXP | | 6480464 | 8-(4-chlorophenylthio)guanosine 3' and 5'-cyclic monophosphorothioate inhibits the reaction [Sildenafil Citrate results in increased expression of CEBPB protein] | CTD | PMID:20471953 |
Cebpb | Mouse | sildenafil citrate | increases expression | EXP | | 6480464 | Sildenafil Citrate results in increased expression of CEBPB mRNA and Sildenafil Citrate results in increased expression of CEBPB protein | CTD | PMID:20471953 |
Cebpb | Mouse | silicon dioxide | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased expression of CEBPB mRNA and Silicon Dioxide results in increased expression of CEBPB mRNA | CTD | PMID:19428942 and PMID:25895662 |
Cebpb | Mouse | silicon dioxide | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Silicon Dioxide results in decreased expression of CEBPB mRNA | CTD | PMID:28425640 |
Cebpb | Mouse | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide results in increased expression of CEBPB mRNA | CTD | PMID:19073995 |
Cebpb | Mouse | silver atom | increases expression | EXP | | 6480464 | Silver results in increased expression of CEBPB mRNA | CTD | PMID:27131904 |
Cebpb | Mouse | silver atom | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Silver results in increased expression of CEBPB mRNA | CTD | PMID:26014281 |
Cebpb | Mouse | silver(0) | increases expression | EXP | | 6480464 | Silver results in increased expression of CEBPB mRNA | CTD | PMID:27131904 |
Cebpb | Mouse | silver(0) | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Silver results in increased expression of CEBPB mRNA | CTD | PMID:26014281 |
Cebpb | Mouse | sincalide | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | [Palmitic Acid co-treated with Sincalide] results in increased expression of CEBPB mRNA more ... | CTD | PMID:26873426 |
Cebpb | Mouse | sodium arsenite | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CEBPB mRNA more ... | CTD | PMID:14523996 and PMID:39836092 |
Cebpb | Mouse | sodium arsenite | affects expression | ISO | CEBPB (Homo sapiens) | 6480464 | sodium arsenite affects the expression of CEBPB mRNA | CTD | PMID:34032870 |
Cebpb | Mouse | Soman | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Soman results in increased expression of CEBPB mRNA | CTD | PMID:19281266 |
Cebpb | Mouse | stavudine | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Stavudine results in increased expression of CEBPB mRNA | CTD | PMID:18299183 |
Cebpb | Mouse | streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of CEBPB protein | CTD | PMID:29266779 |
Cebpb | Mouse | streptozocin | multiple interactions | EXP | | 6480464 | CEBPB protein affects the reaction [Streptozocin results in increased expression of AGT protein] more ... | CTD | PMID:29266779 |
Cebpb | Mouse | sulindac sulfide | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | sulindac sulfide results in increased expression of CEBPB mRNA and sulindac sulfide results in increased expression of CEBPB protein | CTD | PMID:12734198 and PMID:16184548 |
Cebpb | Mouse | sunitinib | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Sunitinib results in increased expression of CEBPB mRNA | CTD | PMID:31533062 |
Cebpb | Mouse | tamibarotene | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | tamibarotene results in increased expression of CEBPB mRNA | CTD | PMID:15498508 |
Cebpb | Mouse | tamoxifen | increases expression | EXP | | 6480464 | Tamoxifen results in increased expression of CEBPB mRNA | CTD | PMID:25123088 |
Cebpb | Mouse | tamoxifen | affects expression | EXP | | 6480464 | Tamoxifen affects the expression of CEBPB mRNA | CTD | PMID:20937368 |
Cebpb | Mouse | tamoxifen | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Tamoxifen results in increased expression of CEBPB mRNA | CTD | PMID:15604281 |
Cebpb | Mouse | tamoxifen | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [Tamoxifen co-treated with ESR2 protein] results in decreased expression of CEBPB mRNA | CTD | PMID:19059307 |
Cebpb | Mouse | tamoxifen | affects expression | ISO | CEBPB (Homo sapiens) | 6480464 | Tamoxifen affects the expression of CEBPB mRNA | CTD | PMID:14699072 |
Cebpb | Mouse | tanespimycin | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | tanespimycin results in decreased expression of CEBPB protein | CTD | PMID:33609515 |
Cebpb | Mouse | Tanshinone I | multiple interactions | EXP | | 6480464 | [indirubin co-treated with tanshinone] promotes the reaction [tetraarsenic tetrasulfide results in increased expression of CEBPB protein] and [indirubin co-treated with tetraarsenic tetrasulfide] promotes the reaction [tanshinone results in increased expression of CEBPB protein] | CTD | PMID:18344322 |
Cebpb | Mouse | Tanshinone I | increases expression | EXP | | 6480464 | tanshinone results in increased expression of CEBPB protein | CTD | PMID:18344322 |
Cebpb | Mouse | tebufenpyrad | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | 4-chloro-N-((4-(1 and 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of CEBPB mRNA | CTD | PMID:33512557 |
Cebpb | Mouse | telbivudine | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Telbivudine results in increased expression of CEBPB mRNA | CTD | PMID:37852574 |
Cebpb | Mouse | telmisartan | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | telmisartan inhibits the reaction [TNF protein promotes the reaction [CEBPB protein binds to IL6 promoter]] | CTD | PMID:19289654 |
Cebpb | Mouse | tert-butyl hydroperoxide | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in increased expression of CEBPB mRNA | CTD | PMID:15336504 |
Cebpb | Mouse | Tesaglitazar | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | tesaglitazar results in increased expression of CEBPB mRNA | CTD | PMID:21270424 |
Cebpb | Mouse | testosterone | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in increased expression of CEBPB mRNA] | CTD | PMID:20032058 |
Cebpb | Mouse | tetrachloromethane | multiple interactions | EXP | | 6480464 | CEBPB protein inhibits the reaction [Carbon Tetrachloride results in increased secretion of and results in increased activity of GPT protein] | CTD | PMID:15721291 |
Cebpb | Mouse | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of CEBPB mRNA | CTD | PMID:31919559 |
Cebpb | Mouse | Tetramethylthiourea | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | tetramethylthiourea inhibits the reaction [Asbestos more ... | CTD | PMID:9378980 |
Cebpb | Mouse | thapsigargin | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Thapsigargin results in increased expression of CEBPB mRNA and Thapsigargin results in increased expression of CEBPB protein alternative form | CTD | PMID:22378314 more ... |
Cebpb | Mouse | thapsigargin | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | Thapsigargin promotes the reaction [CEBPB protein binds to NR1I2 promoter] | CTD | PMID:25616597 |
Cebpb | Mouse | thifluzamide | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | thifluzamide results in increased expression of CEBPB mRNA | CTD | PMID:33512557 |
Cebpb | Mouse | titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of CEBPB mRNA | CTD | PMID:23557971 |
Cebpb | Mouse | titanium dioxide | decreases methylation | EXP | | 6480464 | titanium dioxide results in decreased methylation of CEBPB gene and titanium dioxide results in decreased methylation of CEBPB promoter | CTD | PMID:35295148 |
Cebpb | Mouse | titanium dioxide | decreases expression | EXP | | 6480464 | titanium dioxide results in decreased expression of CEBPB mRNA | CTD | PMID:29264374 |
Cebpb | Mouse | titanium dioxide | affects expression | EXP | | 6480464 | titanium dioxide affects the expression of CEBPB mRNA | CTD | PMID:17656681 |
Cebpb | Mouse | topotecan | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of CEBPB mRNA | CTD | PMID:25729387 |
Cebpb | Mouse | topotecan | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Topotecan results in increased expression of CEBPB mRNA | CTD | PMID:25729387 |
Cebpb | Mouse | torin 1 | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1 more ... | CTD | PMID:30482226 |
Cebpb | Mouse | torin 1 | multiple interactions | EXP | | 6480464 | 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1 more ... | CTD | PMID:30482226 |
Cebpb | Mouse | tributylstannane | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | tributyltin results in increased expression of CEBPB mRNA | CTD | PMID:21683754 and PMID:29908848 |
Cebpb | Mouse | tributylstannane | affects expression | ISO | CEBPB (Homo sapiens) | 6480464 | tributyltin affects the expression of CEBPB mRNA | CTD | PMID:38936095 |
Cebpb | Mouse | Tributyltin oxide | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | bis(tri-n-butyltin)oxide results in increased expression of CEBPB mRNA | CTD | PMID:17553608 |
Cebpb | Mouse | Tributyltin oxide | increases expression | EXP | | 6480464 | bis(tri-n-butyltin)oxide results in increased expression of CEBPB mRNA | CTD | PMID:18958704 |
Cebpb | Mouse | trichloroethene | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of CEBPB mRNA | CTD | PMID:19448997 |
Cebpb | Mouse | trichloroethene | decreases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of CEBPB mRNA | CTD | PMID:19448997 |
Cebpb | Mouse | trichostatin A | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:21911040 and PMID:27188386 |
Cebpb | Mouse | trichostatin A | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | trichostatin A results in increased expression of CEBPB mRNA | CTD | PMID:24935251 and PMID:26272509 |
Cebpb | Mouse | triclosan | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Triclosan results in increased expression of CEBPB mRNA | CTD | PMID:30510588 |
Cebpb | Mouse | triphenyl phosphate | increases expression | EXP | | 6480464 | triphenyl phosphate results in increased expression of CEBPB mRNA | CTD | PMID:28163246 |
Cebpb | Mouse | triphenyl phosphate | affects expression | ISO | CEBPB (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of CEBPB mRNA | CTD | PMID:37042841 |
Cebpb | Mouse | troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of CEBPB mRNA | CTD | PMID:12732648 |
Cebpb | Mouse | troglitazone | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | troglitazone results in increased expression of CEBPB mRNA | CTD | PMID:21515302 and PMID:21877759 |
Cebpb | Mouse | troglitazone | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | troglitazone results in increased expression of CEBPB mRNA | CTD | PMID:19140230 |
Cebpb | Mouse | tunicamycin | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Tunicamycin results in increased expression of CEBPB mRNA | CTD | PMID:22378314 more ... |
Cebpb | Mouse | tunicamycin | multiple interactions | EXP | | 6480464 | CEBPB protein inhibits the reaction [Tunicamycin results in decreased expression of PPARGC1A protein] | CTD | PMID:28482072 |
Cebpb | Mouse | undecane | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | undecane results in increased expression of CEBPB protein | CTD | PMID:17337753 |
Cebpb | Mouse | urethane | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Urethane results in increased expression of CEBPB mRNA | CTD | PMID:28818685 |
Cebpb | Mouse | ursodeoxycholic acid | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | Ursodeoxycholic Acid inhibits the reaction [Deoxycholic Acid results in increased expression of CEBPB] | CTD | PMID:18444174 |
Cebpb | Mouse | valproic acid | increases methylation | ISO | CEBPB (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of CEBPB gene | CTD | PMID:29154799 |
Cebpb | Mouse | valproic acid | increases methylation | ISO | Cebpb (Rattus norvegicus) | 6480464 | Valproic Acid results in increased methylation of CEBPB promoter | CTD | PMID:33150595 |
Cebpb | Mouse | valproic acid | decreases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Valproic Acid results in decreased expression of CEBPB mRNA | CTD | PMID:33150595 |
Cebpb | Mouse | valproic acid | decreases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of CEBPB mRNA | CTD | PMID:29501571 |
Cebpb | Mouse | valproic acid | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPB mRNA | CTD | PMID:27188386 |
Cebpb | Mouse | valproic acid | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of CEBPB mRNA | CTD | PMID:23179753 more ... |
Cebpb | Mouse | vinclozolin | affects expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | vinclozolin affects the expression of CEBPB mRNA | CTD | PMID:19015723 |
Cebpb | Mouse | vincristine | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Vincristine results in increased expression of CEBPB mRNA | CTD | PMID:16001973 |
Cebpb | Mouse | vitamin D | multiple interactions | ISO | CEBPB (Homo sapiens) | 6480464 | [Vitamin D co-treated with bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CEBPB mRNA | CTD | PMID:33836827 |
Cebpb | Mouse | vitamin E | increases response to substance | ISO | CEBPB (Homo sapiens) | 6480464 | CEBPB results in increased susceptibility to Vitamin E | CTD | PMID:9359698 |
Cebpb | Mouse | zearalenone | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | Zearalenone results in increased expression of CEBPB mRNA | CTD | PMID:25424538 |
Cebpb | Mouse | zinc atom | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | [Thymic Factor and Circulating co-treated with Zinc] results in increased activity of CEBPB protein | CTD | PMID:12639846 |
Cebpb | Mouse | zinc atom | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Zinc results in increased expression of CEBPB mRNA | CTD | PMID:17074742 |
Cebpb | Mouse | zinc sulfate | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Zinc Sulfate results in increased expression of CEBPB mRNA | CTD | PMID:17074742 |
Cebpb | Mouse | zinc(0) | multiple interactions | ISO | Cebpb (Rattus norvegicus) | 6480464 | [Thymic Factor and Circulating co-treated with Zinc] results in increased activity of CEBPB protein | CTD | PMID:12639846 |
Cebpb | Mouse | zinc(0) | increases expression | ISO | Cebpb (Rattus norvegicus) | 6480464 | Zinc results in increased expression of CEBPB mRNA | CTD | PMID:17074742 |
Cebpb | Mouse | zoledronic acid | increases expression | ISO | CEBPB (Homo sapiens) | 6480464 | zoledronic acid results in increased expression of CEBPB mRNA | CTD | PMID:24714768 |